ATP ion channel P2X purinergic receptors in inflammation response

Biomed Pharmacother. 2023 Feb:158:114205. doi: 10.1016/j.biopha.2022.114205. Epub 2023 Jan 4.

Abstract

Different studies have confirmed that P2X purinergic receptors play a key role in inflammation. Activation of P2X purinergic receptors can release inflammatory cytokines and participate in the progression of inflammatory diseases. In an inflammatory microenvironment, cells can release a large amount of ATP to activate P2X receptors, open non-selective cation channels, activate multiple intracellular signaling, release multiple inflammatory cytokines, amplify inflammatory response. While P2X4 and P2X7 receptors play an important role in the process of inflammation. P2X4 receptor can mediate the activation of microglia involved in neuroinflammation, and P2X7 receptor can mediate different inflammatory cells to mediate the progression of tissue-wide inflammation. At present, the role of P2X receptors in inflammatory response has been widely recognized and affirmed. Therefore, in this paper, we discussed the role of P2X receptors-mediated inflammation. Moreover, we also described the effects of some antagonists (such as A-438079, 5-BDBD, A-804598, A-839977, and A-740003) on inflammation relief by antagonizing the activities of P2X receptors.

Keywords: ATP; Antagonists; Inflammatory responses; P2X receptors.

Publication types

  • Review

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Cytokines* / metabolism
  • Humans
  • Inflammation
  • Ion Channels*
  • Receptors, Purinergic P2X4
  • Receptors, Purinergic P2X7

Substances

  • Cytokines
  • Ion Channels
  • Receptors, Purinergic P2X4
  • Receptors, Purinergic P2X7
  • Adenosine Triphosphate